Should You Accumulate First Wave BioPharma Inc (FWBI) Stock Wednesday?

First Wave BioPharma Inc (FWBI) stock is down -97.99% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives FWBI stock a score of 34 out of a possible 100.

That rank is primarily influenced by a long-term technical score of 0. FWBI's rank also includes a short-term technical score of 7.

FWBI has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on FWBI!

See Full FWBI Report

What's Happening with FWBI Stock Today

First Wave BioPharma Inc (FWBI) stock is unchanged -0.01% while the S&P 500 is higher by 0.07% as of 2:18 PM on Wednesday, Jul 19. FWBI is unmoved $0.00 from the previous closing price of $0.69 on volume of 1,284,697 shares. Over the past year the S&P 500 has gained 15.78% while FWBI is down -97.99%. FWBI earned $28.20 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 0.02. Click Here to get the full Stock Report for First Wave BioPharma Inc stock.